Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TYLOX-325

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

Standard Dose
325MG;5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TYLOX-325 is listed in Drugs@FDA under application 088246 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 325MG;5MG Sponsor ORTHO MCNEIL PHARM Submission history Latest submission status date: 1984-11-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview TYLOX-325 is listed in Drugs@FDA under application 088246 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 325MG;5MG Sponsor ORTHO MCNEIL PHARM Submission history Latest submission status date: 1984-11-08 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.